Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin
Introduction A significant decrease in red blood cell (RBC) survival has been observed in patients with renal failure, which is supposed to contribute to renal anemia. The aim of this observational study was to determine RBC survival in hemodialysis (HD) patients treated with roxadustat or recombina...
Enregistré dans:
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/860b9687fd1a4d669fcb4f97bae53a00 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|